Guardant Health, Inc. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-21
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.
- Notable: DCaF · Decision Counseling and Follow-up for Shield+ Patients Recruitment opened
- Minor: SOLAR · Shield Post-Approval Study Protocol Trial sites expanded: 69 → 83 locations
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
Not charted: 6 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 13
Colorectal Cancer (5) · Lung Cancer (3) · Breast Cancer (2) · Non-Small Cell Lung Cancer (NSCLC) (2) · Bladder Cancer (1) · Endometrial Cancer (1) · Esophageal Cancer (1) · Gastric Cancer (1) · Head & Neck Cancer (1) · Kidney Cancer (1)
Get alerts when Guardant Health, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.